Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 51 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 70 | 2,945−5.3%/yr | −5.3%/yr | 4.01.2× | 12% | 3,010 in 2030+0.4%/yr |
| Lumbar fusion | 71 | 2,726+1.2%/yr | +1.2%/yr | 3.71.2× | 0% | 3,030 in 2030+1.8%/yr |
| Cervical fusion & disc arthroplasty | 32 | 1,388−3%/yr | −3%/yr | 1.91.1× | 6% | 1,430 in 2030+0.5%/yr |
| Kyphoplasty & vertebroplasty | 12 | 1,040−6.3%/yr | −6.3%/yr | 1.50.8× | 60% | 1,070 in 2030+0.5%/yr |
| SI joint fusion | 3 | 175+24%/yr | +24%/yr | 0.20.7× | 16% | 320 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 333 | 72,572+0.2%/yr | +0.2%/yr | 98.40.8× | 42% | 88,600 in 2030+3.4%/yr |
| Skin substitutes & wound grafts | 38 | 9,735+16%/yr | +16%/yr | 8.30.7× | 69% | 15,600 in 2030+8.1%/yr |
| Bone graft & orthobiologics | 16 | 498−9.2%/yr | −9.2%/yr | 0.71.0× | 3% | 450 in 2030−1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 111 | 8,564+0.4%/yr | +0.4%/yr | 11.60.8× | 88% | 10,900 in 2030+4.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 23 | 1,041+6.2%/yr | +6.2%/yr | 1.41.0× | 47% | 2,170 in 2030+13%/yr |
| Spinal cord & DRG stimulation | 22 | 830+1.8%/yr | +1.8%/yr | 1.11.2× | 70% | 1,040 in 2030+3.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 45 | 5,546−6.3%/yr | −6.3%/yr | 7.51.2× | 70% | 6,500 in 2030+2.7%/yr |
| Superficial venous ablation | 54 | 5,388+1.6%/yr | +1.6%/yr | 7.31.2× | 100% | 5,500 in 2030+0.4%/yr |
| Dialysis access | 37 | 2,923−15%/yr | −15%/yr | 4.30.8× | 53% | 3,040 in 2030+0.7%/yr |
| Thrombectomy, IVC filters & venous stents | 12 | 1,232−0.4%/yr | −0.4%/yr | 1.81.0× | 20% | 1,220 in 2030−0.1%/yr |
| Carotid revascularization | 23 | 1,070−7.3%/yr | −7.3%/yr | 1.51.2× | 0% | 1,090 in 2030+0.3%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 345−9.6%/yr | −9.6%/yr | 0.51.0× | 0% | 400 in 2030+2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 52 | 3,956−4.3%/yr | −4.3%/yr | 6.01.0× | 9% | 4,290 in 2030+1.4%/yr |
| Cholecystectomy & appendectomy | 81 | 3,433−6.8%/yr | −6.8%/yr | 5.01.1× | 4% | 3,630 in 2030+0.9%/yr |
| Colorectal resection | 8 | 1,264−5.6%/yr | −5.6%/yr | 1.81.1× | 0% | 1,230 in 2030−0.4%/yr |
| Antireflux & hiatal hernia surgery | 11 | 544+0.6%/yr | +0.6%/yr | 0.81.0× | 0% | 670 in 2030+3.5%/yr |
| Breast reconstruction | 3 | 337−11%/yr | −11%/yr | 0.51.0× | 6% | 470 in 2030+5.5%/yr |
| Bariatric surgery | 0 | 120−19%/yr | −19%/yr | 0.20.9× | 0% | 190 in 2030+8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 110 | 4,594−3.3%/yr | −3.3%/yr | 6.61.3× | 25% | 4,840 in 2030+0.9%/yr |
| BPH procedures | 62 | 4,487−4.2%/yr | −4.2%/yr | 6.31.3× | 43% | 4,180 in 2030−1.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 43 | 2,360−3.4%/yr | −3.4%/yr | 3.31.3× | 26% | 2,650 in 2030+1.9%/yr |
| Hysterectomy, hysteroscopy & ablation | 25 | 1,879−1.2%/yr | −1.2%/yr | 2.91.1× | 11% | 1,860 in 2030−0.2%/yr |
| Prostatectomy & nephrectomy | 17 | 996−5.4%/yr | −5.4%/yr | 1.61.3× | 0% | 1,110 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 40 | 3,324+0.1%/yr | +0.1%/yr | 4.80.9× | 84% | 4,300 in 2030+4.4%/yr |
| Ear tubes & middle ear surgery | 2 | 283−4.9%/yr | −4.9%/yr | 0.41.2× | 69% | 250 in 2030−2.3%/yr |
| Cochlear implants | 7 | 205+8.7%/yr | +8.7%/yr | 0.31.9× | 28% | 290 in 2030+6.2%/yr |
| Sleep apnea & airway implants | 4 | 136+52%/yr | +52%/yr | 0.20.8× | 0% | 200 in 2030+6.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 81 | 4,468−4.7%/yr | −4.7%/yr | 6.81.0× | 31% | 4,740 in 2030+1%/yr |
| Tumor & fibroid embolization | 13 | 482+8.1%/yr | +8.1%/yr | 0.71.2× | 71% | 1,670 in 2030+23%/yr |
| Tumor ablation | 3 | 213+0.5%/yr | +0.5%/yr | 0.31.0× | 0% | 280 in 2030+4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 150 | 20,740+27%/yr | +27%/yr | 29.01.0× | 93% | 38,400 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 79 | 4,585−3.7%/yr | −3.7%/yr | 6.81.2× | 1% | 4,450 in 2030−0.5%/yr |
| EP ablation | 60 | 3,741+3.6%/yr | +3.6%/yr | 4.41.2× | 0% | 6,340 in 2030+9.2%/yr |
| LAA occlusion & loop recorders | 70 | 2,864+9.6%/yr | +9.6%/yr | 3.51.0× | 3% | 5,150 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 134 | 5,286−10%/yr | −10%/yr | 6.11.0× | 0% | 5,620 in 2030+1%/yr |
| Structural heart (TAVR, TEER) | 67 | 1,854+4.5%/yr | +4.5%/yr | 2.21.5× | 0% | 2,680 in 2030+6.3%/yr |
| Mechanical circulatory support | 2 | 492−1.4%/yr | −1.4%/yr | 0.71.3× | 0% | 420 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 10 | 360−6%/yr | −6%/yr | 0.51.3× | 0% | 300 in 2030−3%/yr |
| Aneurysm & intracranial embolization | 9 | 328+6.6%/yr | +6.6%/yr | 0.51.0× | 0% | 490 in 2030+6.8%/yr |
| DBS & VNS | 4 | 252+1%/yr | +1%/yr | 0.31.1× | 0% | 270 in 2030+1.2%/yr |
| CSF shunts | 2 | 130−2.8%/yr | −2.8%/yr | 0.21.0× | 0% | 130 in 2030+0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 167 | 60,859+2.6%/yr | +2.6%/yr | 85.11.5× | 93% | 72,000 in 2030+2.8%/yr |
| Vitreoretinal surgery | 36 | 2,272−2.5%/yr | −2.5%/yr | 3.31.3× | 77% | 2,320 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 338 | 78,991−4.4%/yr | −4.4%/yr | 117.01.0× | 47% | 84,100 in 2030+1%/yr |
| Bronchoscopy & lung nodule | 58 | 3,989+4.5%/yr | +4.5%/yr | 5.71.8× | 2% | 5,930 in 2030+6.8%/yr |
| ERCP & endoscopic ultrasound | 45 | 1,981−2.7%/yr | −2.7%/yr | 2.90.9× | 7% | 2,310 in 2030+2.6%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.